“…Beginning with the former, significant activity was observed against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) [ 58 , 64 , 65 ], Staphylococcus aureus Newman [ 64 ], Staphylococcus aureus [ 59 , 61 ], Bacillus subtilis [ 59 , 61 , 62 ], Micrococcus luteus [ 61 ], Bacillus cereus [ 61 ], Staphylococcus epidermidis [ 61 ], Enterococcus hirae [ 61 ], vancomycin-sensitive Enterococcus faecalis (VSE) [ 65 ], vancomycin-resistant Enterococcus faecalis (VRE) [ 65 ], and vancomycin-resistant Enterococcus faecium (VRE). Additionally, Gram-negative bacteria were targeted, including Escherichia coli [ 59 , 61 , 62 ], Pseudomonas aeruginosa [ 59 , 61 ], Pseudomonas syringae [ 62 ], Salmonella typhi [ 62 ], and Klebsiella pneumoniae [ 62 ]. Furthermore, enzymatic assays were performed against typical Staphylococcus aureus enzymes, specifically 4,4′-diapophytoene desaturase (CrtN) [ 64 ] and cysteine transpeptidase Sortase A (SrtA) [ 66 ].…”